Correlation Between Opthea and Abeona Therapeutics
Can any of the company-specific risk be diversified away by investing in both Opthea and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Abeona Therapeutics, you can compare the effects of market volatilities on Opthea and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Abeona Therapeutics.
Diversification Opportunities for Opthea and Abeona Therapeutics
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Opthea and Abeona is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Opthea i.e., Opthea and Abeona Therapeutics go up and down completely randomly.
Pair Corralation between Opthea and Abeona Therapeutics
Considering the 90-day investment horizon Opthea is expected to under-perform the Abeona Therapeutics. In addition to that, Opthea is 1.59 times more volatile than Abeona Therapeutics. It trades about -0.38 of its total potential returns per unit of risk. Abeona Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 639.00 in Abeona Therapeutics on August 29, 2024 and sell it today you would lose (36.00) from holding Abeona Therapeutics or give up 5.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Opthea vs. Abeona Therapeutics
Performance |
| Timeline |
| Opthea |
| Abeona Therapeutics |
Opthea and Abeona Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Opthea and Abeona Therapeutics
The main advantage of trading using opposite Opthea and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.The idea behind Opthea and Abeona Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Abeona Therapeutics vs. Bright Minds Biosciences | Abeona Therapeutics vs. HP Inc | Abeona Therapeutics vs. Intel | Abeona Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |